Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL

Clinical trial NCT06742515 · RECRUITING

Trial details

NCT number

NCT06742515

Sponsor

First Affiliated Hospital of Zhejiang University

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2024-10-17

Primary completion

2026-10-01

Enrollment

20

View on ClinicalTrials.gov